Cardiorespiratory adaptation to low-dose dexamethasone for lung disease in extremely preterm infants

The cardiovascular impact of dexamethasone (Dex) is not well understood. Most data are obtained from a 6 week, high-dose regimen, and are limited to findings of hypertension and cardiac hypertrophy. Arvind Sehgal discusses the impact of low-dose Dex on cardiac indices when administered to extremely preterm infants for lung disease.

Read the Study

Image courtesy of interviewee

Log-in or Sign-up to Faculti
Currently viewing this subject insight as a guest. You have insight(s) remaining for this month.

Leave a Reply

Your email address will not be published.

Copyright © Faculti Media Limited 2013 - 2024. All rights reserved.